Davis R M Inc
- SEC CIK
- 0000891287
- Latest filing
- Aug 14, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Davis R M Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −2,785−100.0% | Sold out | Holders |
| Q4 2023 | 2,785 | $212.4K | <0.1% | +2,785 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −2,889−100.0% | Sold out | Holders |
| Q2 2023 | 2,889 | $273.0K | <0.1% | −876−23.3% | Reduced | Holders |
| Q1 2023 | 3,765 | $311.0K | <0.1% | −19−0.5% | Reduced | Holders |
| Q4 2022 | 3,784 | $282.0K | <0.1% | +180+5.0% | Added | Holders |
| Q3 2022 | 3,604 | $298.0K | <0.1% | +729+25.4% | Added | Holders |
| Q2 2022 | 2,875 | $273.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,875 | $338.0K | <0.1% | +175+6.5% | Added | Holders |
| Q4 2021 | 2,700 | $350.0K | <0.1% | −57−2.1% | Reduced | Holders |
| Q3 2021 | 2,757 | $312.0K | <0.1% | +57+2.1% | Added | Holders |
| Q2 2021 | 2,700 | $280.0K | <0.1% | −24−0.9% | Reduced | Holders |
| Q1 2021 | 2,724 | $228.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.